Protein A Resin Market Size, Share, Trends, Growth and Forecast 2032

According to the report published by Zion Market Research, the global Gold Protein A Resin Market size was valued at USD 14.07 Billion in 2023 and is predicted to reach USD 20.06 Billion by the end of 2032. The market is expected to grow with a CAGR of 4.53% during the forecast period. The report analyzes the global Protein A Resin Market’s growth drivers, restraints, and impact on demand during the forecast period. It will also help navigate and explore the arising opportunities in the Protein A Resin Market industry.

Global Protein A Resin Market: Overview

Protein A resin is utilized in the immunoprecipitation of protein, antigens, or protein complexes. Protein A is a kind of bacteria cell wall separated from the class of Staphylococcus aureus that has the ability to bind with the mammalian IgGs majorly from FC regions. Native protein A comprises major 5 IgG binding domains. Recombinant protein also has 5 high-affinity IgG binding domains. Protein A resin is extensively utilized in analyzing contaminated products. Protein A resin chromatography is largely utilized in purifying the materials. Chromatography is being used as a substitute for enhancing the productivity of resin capability of the chromatography purifying process. Protein A resin is also adopted in the affinity resins in bio-manufacturing.

Request Free Sample

Global Protein A Resin Market: Growth Factors

The surging investments in synthetic biology and constant emphasis on drug development by pharmaceutical and biotechnology companies are likely to drive the growth of the global protein A resin market exponentially in the forthcoming years. Furthermore, pharmaceutical companies are highly utilizing protein engineering products in research projects to develop a wide range of protein-based drugs. Thereby, the growing use of chromatography in the process of drug discovery and research will fuel the market growth significantly. However, researchers and scientists have a keen interest in synthetic biology. They are trying to build a noble machine that can efficiently generate synthetic proteins. Moreover, there is a high prevalence of chronic diseases all across the globe which is significantly stressing pharmaceutical companies and government authorities to focus on developing novel therapeutics for disease management.

Also, there is high demand for monoclonal antibodies for treating a wide range of chronic diseases. During the purification process, the anionic impurities in monoclonal antibodies like endotoxin and nucleic acids are eliminated with the help of chromatography. During the drug discovery applications, the purification process utilizes huge amount of resins. Impurities like transferrin and albumin can also be eliminated with the help of size exclusion chromatography. A higher extent of purification can be achieved with the help of protein A affinity resins because the antibodies bind the protein A ligands selectively with resins. However, such emerging landscapes are likely to expedite the growth of the global protein A resin market over the forecast period.

Request Free Sample

Global Protein A Resin Market: Segmentation

The global protein A resin market can be segmented into end-user, application, type, product, and region.

By end-user, the market can be segmented into academic research institutes, pharmaceutical & biopharmaceutical companies, and others. The pharmaceutical & biopharmaceutical company segment accounts for the largest share in the global protein A resin market. The growth can be attributed to the growing expenditure in the pharmaceutical and biopharmaceutical sectors for fueling their research and development activities for the launch of unique products in the market.

By application, the market can be segmented into immunoprecipitation and antibody purification. The antibody purification segment dominates the global protein A resin market due to the growing demand for monoclonal antibodies for research and therapeutic purposes.

By type, the market can be segmented into natural protein A and recombinant protein A.

By product, the market can be segmented into organic polymer-based protein A, silica-based protein A, and agarose-based protein A. The agarose-based protein A segment holds hegemony over others due to its wide utilization for binding ligands and protein.

Gold Protein A Resin Market: Report Scope

Global Protein A Resin Market: Regional analysis

North America accounts for the largest share in the global protein A resin market due to the growing research and development activities undertaken by pharmaceutical companies and research institutes. Also, the surge in demand for monoclonal antibodies for treating the surging prevalence of chronic diseases is likely to further accentuate the growth of the regional market. However, the wide adoption of chromatographic techniques for purifying and identifying biochemicals, which in turn will also steer the growth significantly. In addition, the high prevalence of autoimmune diseases is supporting the growth of the regional market by demanding effective treatment methods.

Asia Pacific is expected to witness a significant growth rate in forthcoming years due to the presence of prominent market leaders in the region. Also, the fast proliferating biopharmaceutical and pharmaceutical sector in the region is another key factor promulgating the growth of the regional market. However, the growing government initiatives are likely to open several lucrative growth opportunities in the regional market. Also, the adoption of protein A resins for the purification process due to the fact that it helps in achieving excellent grade purity will also expedite the growth of the regional market.

Global Protein A Resin Market: Competitive Players

Some of the significant players in the global protein A resin market are:

• Takara Bio Inc.
• Amikozen Co. Ltd.
• Bio-Works Technologies
• JSR Life Sciences
• Avantor
• Agarose Bead Technologies
• Abcam
• Kaneka Corporation
• Orochem
• Bio-Rad Laboratories
• PerkinElmer
• GenScript Biotech Corporation
• Agilent Technologies
• Novasep Holding SAS
• Purolite Corporation
• Tosoh Bioscience
• Thermo Fisher Scientific
• Repligen Corporation
• Merck Millipore
• GE Healthcare.

The Global Protein A Resin Market is segmented as follows:

By end-user 

• academic research institutes
• pharmaceutical & biopharmaceutical companies
• and others

By application 

• immunoprecipitation
• antibody purification 

By type 

• natural protein A
• recombinant protein A

By product 

• organic polymer-based protein A
• silica-based protein A
• agarose-based protein A

Global Protein A Resin Market: Regional Segment Analysis

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

What Reports Provides

• Full in-depth analysis of the parent market
• Important changes in market dynamics
• Segmentation details of the market
• Former, on-going, and projected market analysis in terms of volume and value
• Assessment of niche industry developments
• Market share analysis
• Key strategies of major players
• Emerging segments and regional markets
• Testimonials to companies in order to fortify their foothold in the market.